Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
Maria Febbraio, … , David P. Hajjar, Roy L. Silverstein
Maria Febbraio, … , David P. Hajjar, Roy L. Silverstein
Published September 15, 2001
Citation Information: J Clin Invest. 2001;108(6):785-791. https://doi.org/10.1172/JCI14006.
View: Text | PDF
Perspective

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

  • Text
  • PDF
Abstract

Authors

Maria Febbraio, David P. Hajjar, Roy L. Silverstein

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
CD36-mediated macrophage foam cell formation. In response to EC injury, ...
CD36-mediated macrophage foam cell formation. In response to EC injury, macrophages and LDL transmigrate into the subendothelial space (I), where they may become entrapped. Inflammatory stimuli (II) lead to the secretion of oxidative products from ECs and macrophages, including nitric oxide (NO), hydrogen peroxide, and myeloperoxidase (MPO) (III), which act upon LDL particles and convert them into CD36-specific ligands, or ligands for other scavenger receptors (SR). Internalization of oxidized LDL via CD36 (IV) generates lipid byproducts (e.g., 9-HODE, 13-HODE, and PGJ2), mediated by lipoxygenase or other pathways, which in turn provide ligands for the transcription factor PPARγ (V). The binding of these lipids structurally enables PPARγ to dimerize with binding partners such as RXR and charges the complex for nuclear translocation and the activation of transcription of target genes (VI). Because these target genes include both PPARγ and CD36, a positive feedback loop arises. The increased expression of CD36 promotes further oxidized LDL uptake, perpetuating the cycle and resulting in accumulation of cholesterol ester by macrophages and eventually in foam cell formation (VII). Adapted from ref. 48.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts